This phase I and II study will determine the safety and toxicity of the chemotherapy regimen Adriamycin, Bleomycin, and Vincristine (ABV) for advanced AIDS-Related Kaposi's Sarcoma in combination with either dideoxyinosine (ddI0 or dideoxycitidine (ddC) at doses generally used in current treatment of IND studies.
Showing the most recent 10 out of 767 publications